10:31 ETHyperphosphatemia Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Novel Therapeutics and Rising CKD Burden | DelveInsightprnewswire·Aug 5 at 09:33 AMUNCY+7.80%4581
21:01 ETKaigene Enters into Exclusive Licensing Agreement with Taisho Pharmaceutical for Next-Generation Autoimmune Asset KG006 in Japanprnewswire·Jul 30 at 08:03 PM4581
Kasumigaseki Capital partners with Taisho Pharmaceutical on heatstroke prevention project for construction workersPUBT·Jul 29 at 01:47 AM34984581
